U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 10 of 13 results

Status:
US Approved Rx (2020)
First approved in 2011

Class (Stereo):
CHEMICAL (ABSOLUTE)



Icatibant (trade name Firazyr) is a synthetic peptidomimetic drug consisting of ten amino acids, and acts as an effective and specific antagonist of bradykinin B2 receptors. It has been approved in the EU for use in hereditary angioedema, and is unde...
Status:
US Approved Rx (1983)
First approved in 1983

Class (Stereo):
CHEMICAL (ACHIRAL)



Hemin (trade name Panhematin) is a protoporphyrin IX containing a ferric iron ion (heme B) with a chloride ligand, which is is indicated for the amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cyc...
mixture
Status:
US Approved Rx (2004)
First approved in 1949

Class:
MIXTURE

mixture
Status:
US Previously Marketed
First approved in 1962

Class:
MIXTURE

mixture
Status:
US Previously Marketed
First approved in 1951

Class:
MIXTURE

Status:
US Approved Rx (2009)
First approved in 2009

Class:
PROTEIN



Ecallantide (DX-88) is a potent and specific inhibitor of plasma kallikrein. Ecallantide is a recombinantly produced and engineered small protein based on the first Kunitz domain of human tissue factor pathway inhibitor. It was identified through pha...
Status:
US Previously Marketed
First approved in 1959

Class:
PROTEIN

Status:
US Previously Marketed
First approved in 1955

Class:
PROTEIN

Status:
US Approved Rx (2018)
First approved in 2018

Class:
PROTEIN

Status:
US Approved Rx (2014)
First approved in 2014

Class:
PROTEIN

Showing 1 - 10 of 13 results